DIGE Digene Corp (MM)

GAITHERSBURG, Md., Jan. 18 /PRNewswire-FirstCall/ -- Digene Corporation (NASDAQ:DIGE) today announced plans to release financial results for the fiscal 2007 second quarter and three months ended December 31, 2006 at the close of market on Thursday, February 1, 2007. Digene will host a conference call, which will be broadcast live over the Internet on Thursday, February 1, 2007 at 4:30 p.m. EST. The broadcast will be hosted on the Company's website located at http://www.digene.com/. Please allow extra time prior to the call to visit the site and download the streaming media software required to listen to the Internet broadcast. The online archive of the broadcast will be available within two hours of the live call and can be accessed through May 1, 2007, by dialing (800) 308- 7860 or (203) 369-3244. About Digene A leader in molecular diagnostics, Digene develops, manufactures and markets proprietary DNA and RNA tests, with a focus on women's health. The company's flagship product, the Digene(R) HPV Test, is the only FDA-approved and CE-marked test for the human papillomavirus, the cause of essentially all cervical cancers. Digene's product portfolio also includes tests for the detection of other sexually transmitted infections, including chlamydia and gonorrhea. Digene tests are marketed in more than 40 countries worldwide. Headquartered in Gaithersburg, MD, Digene is traded on NASDAQ under the symbol DIGE. For more information, visit http://www.digene.com/ and http://www.thehpvtest.com/. DATASOURCE: Digene Corporation CONTACT: Albert Fleury, Investor Relations, Digene Corporation, +1-301-944-7000, or Investors, Evan Smith, Financial Dynamics, +1-212-850-5606, or Media, Pam Rasmussen, Digene, +1-301-944-7196 Web site: http://www.digene.com/ http://www.thehpvtest.com/

Copyright